Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats
Open Access
- 7 August 2002
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 3 (1) , 19
- https://doi.org/10.1186/1471-2474-3-19
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Alendronate in the treatment of avascular necrosis of the hipRheumatology, 2002
- Bone allografts pretreated with a bisphosphonate are not resorbedActa Orthopaedica, 2002
- Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.2000
- The Ranawat Award. Histology of nine structural bone grafts used in total knee arthroplasty.1997
- Basic Fibroblast Growth Factor Promotes Bone Ingrowth in Porous HydroxyapatiteClinical Orthopaedics and Related Research, 1996
- CELLS OF THE MONONUCLEAR PHAGOCYTE SERIES DIFFERENTIATE INTO OSTEOCLASTIC LACUNAR BONE RESORBING CELLSThe Journal of Pathology, 1996
- Increased bone ingrowth distance into lipid-extracted bank bone at 6 weeksArchives of orthopaedic and trauma surgery, 1995
- Basic fibroblast growth factor and bone induction in ratsActa Orthopaedica, 1993
- The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment.1979